Skip to main content
Fig. 4 | European Journal of Medical Research

Fig. 4

From: Infection and the evaluation of biomarkers in obstetrics and gynecology patients with infectious disease: a retrospective observational study from clinical pharmacists’ consultation experience

Fig. 4

Top five pathogens detected in the patients and the corresponding treatment regimens Notes: Imipenem–cilastatin-based: Imipenem–cilastatin ± amikacin/azithromycin/fluconazole/fosfomycin/vancomycin. Piperacillin tazobactam based: Piperacillin tazobactam ± amikacin/ornidazole/fosfomycin/vancomycin/metronidazole/cefoxitin; Levofloxacin based: Levofloxacin ± amikacin/ornidazole/fosfomycin. Meropenem based: Meropenem ± fluconazole/fosfomycin/tigecycline/vancomycin/ornidazole

Back to article page